RNS 13TH June 20192 Jan 2020 18:50
And on taking Vulpes stake, Marin Diggle said this...........................
Martin Diggle, Co-Founder and Portfolio Manager, Vulpes Investment Management, said:
"I am very pleased to be investing in Scancell at this exciting time in the company's evolution. Vulpes has been conducting scientific and commercial due diligence on Scancell for a considerable period of time. We have concluded the company's unique and innovative approach to fighting cancer is compelling and under-appreciated. At Vulpes we are always searching for overlooked companies that have the ability to make significant advances in medical science, with a view to supporting their development over the long term. We believe Scancell fulfil these criteria perfectly."
That will do for me, and now with a further holding RNSs, there is something they like very much, hence our rise IMHO